Drug Therapy
Drug Therapy
09/01/2017
The US Food and Drug Administration has approved a new treatment option for adult and pediatric patients with CD33-positive acute myeloid leukemia.
09/01/2017
Drug Therapy
Drug Therapy
09/01/2017
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved a new option for adult patients with tardive dyskinesia.
09/01/2017
Drug Therapy
Drug Therapy
09/01/2017
After clinical trials demonstrated its safety and efficacy, the US Food and Drug Administration approved a new option for adult patients with tardive dyskinesia.
09/01/2017
FDA
FDA
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017
FDA
FDA
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017
FDA
FDA
08/30/2017
The FDA has approved the first CAR T-cell therapy available in the United States for the treatment of certain pediatric patients.
08/30/2017
FDA
FDA
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
08/30/2017
The US Food and Drug Administration has approved a new treatment option for adult patients with complicated urinary tract infections, including pyelonephritis.
08/30/2017
FDA
FDA
08/30/2017
After clinical trials demonstrated its efficacy and safety, a new treatment option for children with Chagas disease has been approved by the US Food and Drug Administration.
08/30/2017